Therapeutic Lymphangiogenesis Is a Promising Strategy for Secondary Lymphedema
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24097774 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yuuki Shimizu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan. Hauptthemen laut MEDLINE: Lymphangiogenesis, Lymphatic Vessels, Lymphedema. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology of Japan.
Abstract (Originalsprache)
Secondary lymphedema is caused by lymphatic insufficiency (lymphatic drainage failure) following lymph node dissection during the surgical treatment or radiation therapy of breast or pelvic cancer. The clinical problems associated with lymphedema are reduced quality of life in terms of appearance and function, as well as the development of skin ulcers, recurrent pain, and infection. Currently, countermeasures against lymphedema are mainly physical therapy such as lymphatic massage, elastic stockings, and skin care, and there is no effective and fundamental treatment with a highly recommended grade. Therefore, there is a need for the development of a fundamental novel treatment for intractable lymphedema. Therapeutic lymphangiogenesis, which has been attracting attention in recent years, is a treatment concept that reconstructs the fragmented lymphatic network to recover lymphatic vessel function and is revolutionary to be a fundamental cure. This review focuses on the translational research of therapeutic lymphangiogenesis for lymphedema and outlines the current status and prospects in the development of therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
ORCID-Profile: Yuuki Shimizu
Förderung
- Ministry of Education, Culture, Sports, Science and Technology of Japan
Zitieren
APA
Shimizu, Y., Che, Y., & Murohara, T. (2023). Therapeutic Lymphangiogenesis Is a Promising Strategy for Secondary Lymphedema. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24097774
Vancouver
Shimizu Y, Che Y, Murohara T. Therapeutic Lymphangiogenesis Is a Promising Strategy for Secondary Lymphedema. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24097774
BibTeX
@article{Shimizu2023,
author = {Shimizu, Yuuki and Che, Yiyang and Murohara, Toyoaki},
title = {Therapeutic Lymphangiogenesis Is a Promising Strategy for Secondary Lymphedema},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24097774}
}
EUVIMED